Patent details

EP2699091 Title: 2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS

Basic Information

Publication number:
EP2699091
PCT Application Number:
US2012030870
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127648954
PCT Publication Number:
WO2012135299
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS
French Title of Invention:
COMPOSÉS DE 2',6'-DIOXO-3'-DEUTÉRO-PIPÉRIDIN-3-YL-ISOINDOLINE
German Title of Invention:
2',6'-DIOXO-3'-DEUTERO-PIPERIDIN-3-YL-ISOINDOLIN-VERBINDUNGEN
SPC Number:

Dates

Filing date:
28/03/2012
Grant date:
21/06/2017
EP Publication Date:
26/02/2014
PCT Publication Date:
04/10/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/06/2017
EP B1 Publication Date:
21/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/03/2018
Expiration date:
28/03/2032
Renunciation date:
Revocation date:
16/06/2019
Annulment date:

Owner

From:
21/06/2017
 
 

Name:
DeuteRx, LLC
Address:
300 Brickstone Square Suite 201, Andover MA 01810, United States (US)

Inventor

Name:
DEWITT, Sheila
Address:
United States (US)

Priority

Priority Number:
201161468179 P
Priority Date:
28/03/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/454; A61P 25/28; A61P 29/00; A61P 35/00; C07D 401/04;

Publication

European Patent Bulletin

1

Issue number:
201725
Publication date:
21/06/2017
Description:
Grant (B1)

2

Issue number:
201943
Publication date:
23/10/2019
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/07/2018 Outgoing Correspondence 1